180 related articles for article (PubMed ID: 19679126)
1. Anti-inflammatory treatment in AD mice protects against neuronal pathology.
Choi JK; Jenkins BG; Carreras I; Kaymakcalan S; Cormier K; Kowall NW; Dedeoglu A
Exp Neurol; 2010 Jun; 223(2):377-84. PubMed ID: 19679126
[TBL] [Abstract][Full Text] [Related]
2. Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.
Jantzen PT; Connor KE; DiCarlo G; Wenk GL; Wallace JL; Rojiani AM; Coppola D; Morgan D; Gordon MN
J Neurosci; 2002 Mar; 22(6):2246-54. PubMed ID: 11896164
[TBL] [Abstract][Full Text] [Related]
3. The effects of aging, housing and ibuprofen treatment on brain neurochemistry in a triple transgene Alzheimer's disease mouse model using magnetic resonance spectroscopy and imaging.
Choi JK; Carreras I; Aytan N; Jenkins-Sahlin E; Dedeoglu A; Jenkins BG
Brain Res; 2014 Nov; 1590():85-96. PubMed ID: 25301691
[TBL] [Abstract][Full Text] [Related]
4. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.
Lim GP; Yang F; Chu T; Chen P; Beech W; Teter B; Tran T; Ubeda O; Ashe KH; Frautschy SA; Cole GM
J Neurosci; 2000 Aug; 20(15):5709-14. PubMed ID: 10908610
[TBL] [Abstract][Full Text] [Related]
5. R-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer's disease.
Carreras I; McKee AC; Choi JK; Aytan N; Kowall NW; Jenkins BG; Dedeoglu A
Brain Res; 2013 Dec; 1541():115-27. PubMed ID: 24161403
[TBL] [Abstract][Full Text] [Related]
6. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
Pasinetti GM
J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.
Yan Q; Zhang J; Liu H; Babu-Khan S; Vassar R; Biere AL; Citron M; Landreth G
J Neurosci; 2003 Aug; 23(20):7504-9. PubMed ID: 12930788
[TBL] [Abstract][Full Text] [Related]
8. Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.
Morihara T; Teter B; Yang F; Lim GP; Boudinot S; Boudinot FD; Frautschy SA; Cole GM
Neuropsychopharmacology; 2005 Jun; 30(6):1111-20. PubMed ID: 15688088
[TBL] [Abstract][Full Text] [Related]
9. Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation.
Thomas T; Nadackal TG; Thomas K
Neuroreport; 2001 Oct; 12(15):3263-7. PubMed ID: 11711868
[TBL] [Abstract][Full Text] [Related]
10. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
[TBL] [Abstract][Full Text] [Related]
11. Identification and modification of amyloid-independent phenotypes of APOE4 mice.
DiBattista AM; Dumanis SB; Newman J; Rebeck GW
Exp Neurol; 2016 Jun; 280():97-105. PubMed ID: 27085394
[TBL] [Abstract][Full Text] [Related]
12. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C
Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410
[TBL] [Abstract][Full Text] [Related]
13. NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.
Varvel NH; Bhaskar K; Kounnas MZ; Wagner SL; Yang Y; Lamb BT; Herrup K
J Clin Invest; 2009 Dec; 119(12):3692-702. PubMed ID: 19907078
[TBL] [Abstract][Full Text] [Related]
14. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.
Weggen S; Eriksen JL; Das P; Sagi SA; Wang R; Pietrzik CU; Findlay KA; Smith TE; Murphy MP; Bulter T; Kang DE; Marquez-Sterling N; Golde TE; Koo EH
Nature; 2001 Nov; 414(6860):212-6. PubMed ID: 11700559
[TBL] [Abstract][Full Text] [Related]
15. Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice.
Chen SQ; Wang PJ; Ten GJ; Zhan W; Li MH; Zang FC
Dement Geriatr Cogn Disord; 2009; 28(6):558-66. PubMed ID: 20093832
[TBL] [Abstract][Full Text] [Related]
16. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.
Takeuchi A; Irizarry MC; Duff K; Saido TC; Hsiao Ashe K; Hasegawa M; Mann DM; Hyman BT; Iwatsubo T
Am J Pathol; 2000 Jul; 157(1):331-9. PubMed ID: 10880403
[TBL] [Abstract][Full Text] [Related]
17. No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease.
Hillmann A; Hahn S; Schilling S; Hoffmann T; Demuth HU; Bulic B; Schneider-Axmann T; Bayer TA; Weggen S; Wirths O
Neurobiol Aging; 2012 Apr; 33(4):833.e39-50. PubMed ID: 21943956
[TBL] [Abstract][Full Text] [Related]
18. Effects of celecoxib and ibuprofen on metabolic disorders induced by Walker-256 tumor in rats.
de Souza CO; Kurauti MA; de Fatima Silva F; de Morais H; Borba-Murad GR; de Andrade FG; de Souza HM
Mol Cell Biochem; 2015 Jan; 399(1-2):237-46. PubMed ID: 25359170
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of anti-inflammatory proteins in human rheumatoid synoviocyte MH7A cell by celecoxib and ibuprofen.
Heum Park J; Cho Han D; Kim J; Hyung Hong S; Lee SK; Seog Yoon K; Min Kim J; Son KH; Miyazawa K; Kwon BM
Life Sci; 2006 Apr; 78(19):2204-12. PubMed ID: 16289138
[TBL] [Abstract][Full Text] [Related]
20. CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease.
Imbimbo BP; Hutter-Paier B; Villetti G; Facchinetti F; Cenacchi V; Volta R; Lanzillotta A; Pizzi M; Windisch M
Br J Pharmacol; 2009 Mar; 156(6):982-93. PubMed ID: 19239474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
